$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--CCRN, EEX, BLD, and QXO
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--CCRN, EEX, BLD, and QXO PR Newswire
CCRN - Cross Country Healthcare, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$10.61
DETAILS
HIGH:
$14.00
LOW:
$8.65
MEDIAN:
$10.50
CONSENSUS:
$10.61
DOWNSIDE:
18.70%
Stock News
CCRN Investors Have Opportunity to Join Cross Country Healthcare, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES, May 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cross Country Healthcare, Inc. (“Cross Country” or “the Company”) (NASDAQ: CCRN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Cross Country Expands AI-Powered Workforce Intelligence for Health Systems Through Exclusive Optimé Solution
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (Nasdaq: CCRN), a technology-driven healthcare workforce solutions company, today announced an exclusive 36-month partnership to bring the Optimé workforce strategy and planning solution into Intellify®, Cross Country's workforce intelligence platform. Optimé adds advanced forecasting, analytics and workforce optimization capabilities to Intellify, helping health systems better align workforce supply with patient demand, improve.
CCRN Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Cross Country Healthcare to Knox Lane
MONSEY, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Cross Country Healthcare (Nasdaq: CCRN) (“CCRN”) for $13.25 per share in cash to Knox Lane, a private equity firm.
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cross Country Healthcare, Inc. (NASDAQ: CCRN)
NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.
CCRN Investors Have Opportunity to Join Cross Country Healthcare, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cross Country Healthcare, Inc. (“Cross Country” or “the Company”) (NASDAQ: CCRN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Cross Country Healthcare (CCRN) Reports Q1 Loss, Beats Revenue Estimates
Cross Country Healthcare (CCRN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to earnings of $0.06 per share a year ago.
Here's What Key Metrics Tell Us About Cross Country (CCRN) Q1 Earnings
While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cross Country Healthcare Announces First Quarter 2026 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2026. Selected Financial Information: Variance Variance Q1 2026 vs Q1 2026 vs Dollars are in thousands, except per share amounts Q1 2026 Q1 2025 Q4 2025 Revenue $ 241,057 (18) % 2 % Gross profit margin* 19.7 % (30) bps (60) bps Net loss attributable to common stockholders $ (4,266) (771) % 95 % Dilu.
Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million
BOCA RATON, Fla. & SAN FRANCISCO--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (NASDAQ: CCRN) (“Cross Country Healthcare” or the “Company”) a leading, technology-driven healthcare workforce solutions company, today announced that it has entered into a definitive agreement to be acquired by Knox Lane, a growth-oriented investment firm. Under the terms of the agreement, Knox Lane will acquire all outstanding shares of Cross Country Healthcare common stock for $13.25 per share in an all-cash tr.
Cross Country Healthcare Marks 40 Years, Accelerates Next Generation of Workforce Intelligence and Orchestration
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare marks 40 years with expanded AI and predictive analytics to advance workforce intelligence and orchestration.
Cross Country Appoints Chris Tyrell as Chief Information Officer to Support Next Phase of Enterprise AI and Platform Strategy
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country names Chris Tyrell CIO, driving enterprise technology execution and investment across AI, automation, and platform strategy.
Cross Country Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026 at 5:00 P.M. Eastern Time. Cross Country Healthcare, Inc. (the “Company”) intends to distribute its earnings press release after market close on Thursday, May 7, 2026. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 800-369-2163 from an.
5 Broker-Liked Stocks Worth Tracking Amid the Middle East Conflict
Broker-favored stocks like PSX, CABO and others stand out as Iran-Israel war jolts oil and markets.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Given Consensus Rating of “Hold” by Brokerages
Cross Country Healthcare, Inc. (NASDAQ: CCRN - Get Free Report) has been assigned a consensus rating of "Hold" from the nine analysts that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and three have issued a buy recommendation on the company. The
Cross Country Healthcare and Open Hearts for Orphans Announce Community Partnership to Strengthen Families and Support Vulnerable Children
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country and Open Hearts for Orphans unite to support families, strengthen communities, and improve outcomes for vulnerable children.
Cross Country (CCRN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cross Country Healthcare, Inc. (CCRN) Q4 2025 Earnings Call Transcript
Cross Country Healthcare, Inc. (CCRN) Q4 2025 Earnings Call Transcript
Cross Country Healthcare (CCRN) Reports Q4 Loss, Lags Revenue Estimates
Cross Country Healthcare (CCRN) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.04 per share a year ago.
Cross Country Healthcare Announces Fourth Quarter and Full Year 2025 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company,” “Cross Country,” “we,” “us,” and “our”) (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2025. SELECTED FINANCIAL INFORMATION: Dollars are in thousands, except per share amounts Q4 2025 Variance Q4 2025 vs Q4 2024 Variance Q4 2025 vs Q3 2025 Full Year 2025 Variance 2025 vs 2024 Revenue $ 236,761 (24 ) % (5 ) % $ 1,054,293 (22 ) % Gross profit ma.
Price Targets
Benchmark Upgrades Cross Country Healthcare (CCRN) to Buy
$14.00
(was $9.68)
Bill Sutherland
·
Cross Research
Cross Country Healthcare initiated with a Neutral at Wedbush
$11.00
(was $9.29)
Wedbush
Cross Country Healthcare price target lowered to $10 from $18.61 at Truist
$10.00
(was $8.16)
Truist Financial
Cross Country Healthcare price target lowered to $9 from $16.50 at UBS
$9.00
(was $8.14)
UBS
Cross Country Healthcare price target lowered to $8.65 from $12.29 at Jefferies
$8.65
(was $7.46)
Jack Slevin
·
Jefferies
Cross Country upgraded to Outperform from Market Perform at Citizens JMP
$11.00
(was $7.46)
Constantine Davides
·
JMP Securities
Cross Country Healthcare price target lowered to $21 from $24 at Barrington
$21.00
(was $16.58)
Kevin Steinke
·
Barrington